🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the efficacy and safety of ombitasvir/paritaprevir/rit...
Status
Completed
Location
Multiple Locations
Start Date
2015-09-30
Trial ID
NCT02487199
Treatments Being Tested
The purpose of this phase 3, multicenter study is to evaluate the efficacy ...
Status
Completed
Location
Multiple Locations
Start Date
2016-02-22
Trial ID
NCT02707952
Treatments Being Tested
Cyclosporine A (CsA) is a common long-term treatment used to inhibit the im...
Status
Completed
Location
University of Minnesota, ACTU
Start Date
2004-02
Trial ID
NCT00084149
Treatments Being Tested
The primary objective of the study is to evaluate the efficacy of a booster...
Status
Enrolling By Invitation
Location
Cantonal Hospital Aarau
Start Date
2023-11-13
Trial ID
NCT06037564
Treatments Being Tested
This study will assess the pharmacokinetics of TDF in Thai HIV-infected chi...
Status
Completed
Location
Khon Kaen University
Start Date
2010-06
Trial ID
NCT02404259
Treatments Being Tested
The purpose of this study is to evaluate the Pharmacokinetics of Danoprevir...
Status
Completed
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT03019991
Treatments Being Tested
The purpose of this study is to determine whether atazanavir powder combine...
Status
Completed
Location
Local Institution
Start Date
2010-10-13
Trial ID
NCT01099579
Treatments Being Tested
This open-label study will evaluate the safety, pharmacokinetics and antivi...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01638650
Treatments Being Tested
A study to investigate the fraction of ABT-267 and ABT-450 absorbed by the ...
Status
Completed
Location
Site Reference ID/Investigator# 118615
Start Date
2014-01
Trial ID
NCT02052362
Treatments Being Tested
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested